813 related articles for article (PubMed ID: 32781391)
1. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
5. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
[TBL] [Abstract][Full Text] [Related]
6. Geneticin ameliorates pulmonary fibrosis by attenuating the TGF-β/Smad via modulating AMPK/SIRT1 signaling.
Tirunavalli SK; Andugulapati SB
Life Sci; 2024 Jun; 346():122626. PubMed ID: 38614295
[TBL] [Abstract][Full Text] [Related]
7. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
9. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
[TBL] [Abstract][Full Text] [Related]
10. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
13. Targeting TGF-β/periostin signaling by sesamol ameliorates pulmonary fibrosis and improves lung function and survival.
Tirunavalli SK; Kuncha M; Sistla R; Andugulapati SB
J Nutr Biochem; 2023 Jun; 116():109294. PubMed ID: 36948431
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
15. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
16. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
17. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
[TBL] [Abstract][Full Text] [Related]
18. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
Li X; Yu H; Liang L; Bi Z; Wang Y; Gao S; Wang M; Li H; Miao Y; Deng R; Ma L; Luan J; Li S; Liu M; Lin J; Zhou H; Yang C
Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
[TBL] [Abstract][Full Text] [Related]
19. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
20. Kurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways.
Park SJ; Kim TH; Lee K; Kang MA; Jang HJ; Ryu HW; Oh SR; Lee HJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
